{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:44:04Z","timestamp":1793184244968,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.pnpbp.2007.08.032","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T07:15:15Z","timestamp":1188458115000},"page":"348-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Stereotypic behaviour in the deer mouse: Pharmacological validation and relevance for obsessive compulsive disorder"],"prefix":"10.1016","volume":"32","author":[{"given":"Schaun","family":"Korff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"J. Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"H. Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.08.032_bib1","series-title":"Diagnostic and statistical manual of mental disorders","first-page":"417","article-title":"American Psychiatric Association","author":"APA","year":"2000"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.pnpbp.2005.04.019","article-title":"A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism","volume":"29","author":"Baca-garcia","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-3223(98)00154-1","article-title":"Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder","volume":"45","author":"Bergqvist","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00041444-199521000-00006","article-title":"Psychiatric disorders in relatives of probands with obsessive-compulsive disorder and co-morbid major depression or generalized anxiety","volume":"5","author":"Black","year":"1995","journal-title":"Psychiatric Genetics"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0140525X06009332","article-title":"Why ritualized behavior? Precaution systems and action parsing in developmental, pathological and cultural rituals","volume":"29","author":"Boyer","year":"2006","journal-title":"Behav Brain Sci"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0306-4530(99)00061-X","article-title":"Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation","volume":"25","author":"Brambilla","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1988.01800260095012","article-title":"Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects","volume":"45","author":"Charney","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0031-9384(03)00047-7","article-title":"Compulsive behavior in the 5-HT2C receptor knockout mouse","volume":"78","author":"Chou-Green","year":"2003","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050327","article-title":"Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies","volume":"132","author":"Crawley","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.psc.2006.02.013","article-title":"Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders","volume":"29","author":"Denys","year":"2006","journal-title":"Psychiatr Clin North Am"},{"issue":"suppl 14","key":"10.1016\/j.pnpbp.2007.08.032_bib12","first-page":"11","article-title":"The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence","volume":"65","author":"Denys","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pnpbp.2005.11.005","article-title":"Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder","volume":"30","author":"El Mansari","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(97)01474-X","article-title":"Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice","volume":"341","author":"Gleason","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib16","first-page":"36","article-title":"Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?","volume":"51","author":"Goodman","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-3223(94)00235-U","article-title":"m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation","volume":"38","author":"Goodman","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib17","series-title":"The psychobiology of obsessive-compulsive disorder","first-page":"162","article-title":"Pharmacologic challenges in obsessive-compulsive disorder","author":"Goodman","year":"1991"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000079970","article-title":"Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan","volume":"50","author":"Gross-Isseroff","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.333.7565.424","article-title":"Obsessive-compulsive disorder","volume":"333","author":"Heyman","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archpsyc.1992.01820010021003","article-title":"Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers","volume":"49","author":"Hollander","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0006-3223(97)00458-7","article-title":"Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls","volume":"44","author":"Ho Pian","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(91)90113-4","article-title":"Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder","volume":"36","author":"Hollander","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1176\/ajp.145.8.1015","article-title":"Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings","volume":"145","author":"Hollander","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib24","first-page":"365","article-title":"Obsessive-compulsive disorder: a neuroethological perspective","volume":"24","author":"Insel","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0306-4530(00)00048-2","article-title":"Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder","volume":"26","author":"Khanna","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.psc.2006.02.007","article-title":"Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology","volume":"29","author":"Korff","year":"2006","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib27","series-title":"Neurocircuitry and neuroautonomic disorders: Reviews and therapeutic strategies","first-page":"57","article-title":"Neuroautonomic, neuroendocrine and neuroimmune interactions","author":"Lechin","year":"2002"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3565(24)37669-4","article-title":"5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential","volume":"286","author":"Martin","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archpsyc.61.6.564","article-title":"Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder","volume":"61","author":"Mataix-Cols","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpsyc.1994.03950040046006","article-title":"Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics","volume":"51","author":"McDougle","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/archpsyc.1969.01740200112015","article-title":"Animal models of depression. I. Review of the evidence: implications for research","volume":"21","author":"McKinney","year":"1969","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.pnpbp.2005.06.002","article-title":"Paradoxical rate-dependent effect of fluoxetine on captivity-induced stereotypies in bank voles","volume":"29","author":"Meers","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0166-4328(02)00194-8","article-title":"Chronic administration of fluoxetine impairs inhibitory avoidance in male but not female mice","volume":"136","author":"Monleon","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-3223(93)90272-F","article-title":"A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP","volume":"33","author":"Pigott","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib35","first-page":"343","article-title":"Growth hormone response to apomorphine in obsessive-compulsive disorder","volume":"21","author":"Pitchot","year":"1996","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0031-9384(98)00303-5","article-title":"A rodent model of spontaneous stereotypy: initial characterization of developmental, environmental, and neurobiological factors","volume":"66","author":"Powell","year":"1999","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.physbeh.2003.09.008","article-title":"Effects of intrastriatal administration of selective dopaminergic ligands on spontaneous stereotypy in mice","volume":"80","author":"Presti","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbr.2004.08.003","article-title":"Striatal opioid peptide content in an animal model of spontaneous stereotypic behavior","volume":"157","author":"Presti","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0091-3057(02)01081-X","article-title":"Selective blockade of spontaneous motor stereotypy via intrastriatal pharmacological manipulation","volume":"74","author":"Presti","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.npp.1300017","article-title":"Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice","volume":"28","author":"Ralph-Williams","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-2000-8360","article-title":"Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs","volume":"33","author":"Ramasubbu","year":"2000","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0301-0082(94)90039-6","article-title":"The psychology of perseverative and stereotyped behavior","volume":"44","author":"Ridley","year":"1994","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1037\/0735-7044.97.5.830","article-title":"Automated measurement of stereotypic behaviour in rats","volume":"97","author":"Sanberg","year":"1983","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0091-3057(87)90369-8","article-title":"Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats","volume":"27","author":"Sanberg","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0193-953X(05)70181-7","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder","volume":"23","author":"Saxena","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0168-1591(02)00210-1","article-title":"Stimulation of serotonin (5-HT) activity reduces spontaneous stereotypies in female but not in male bank voles (Clethrionomys glareolus). Stereotyping female voles as a new animal model for human anxiety and mood disorders","volume":"80","author":"Schoenecker","year":"2003","journal-title":"Appl Anim Behav Sci"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0006-3223(99)00271-1","article-title":"Neurobiology of the obsessive-compulsive spectrum disorders","volume":"47","author":"Stein","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1037\/0735-7044.112.6.1475","article-title":"Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD)","volume":"112","author":"Szechtman","year":"1998","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0091-3057(97)00332-8","article-title":"Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats","volume":"58","author":"Van Hartesveldt","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0091-3057(96)00321-8","article-title":"Effect of apomorphine on the conflict-induced jumping stereotypy in bank voles","volume":"57","author":"Vandebroek","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib51","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.neuropharm.2004.07.035","article-title":"Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor","volume":"47","author":"Vinet","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pscychresns.2004.07.001","article-title":"A meta-analysis of functional neuroimaging in obsessive-compulsive disorder","volume":"132","author":"Whiteside","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib53","series-title":"Behavioural models in psychopharmacology: theoretical, industrial and clinical perspectives","first-page":"3","article-title":"Behavioural models in psychopharmacology","author":"Wilner","year":"1991"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0006-3223(87)90199-5","article-title":"Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology","volume":"22","author":"Zohar","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib55","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.1987.01800230026006","article-title":"Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls","volume":"44","author":"Zohar","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.08.032_bib56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archpsyc.1988.01800260081011","article-title":"Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment","volume":"45","author":"Zohar","year":"1988","journal-title":"Arch Gen Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858460700320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858460700320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:40:34Z","timestamp":1759520434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858460700320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S027858460700320X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.08.032","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotypic behaviour in the deer mouse: Pharmacological validation and relevance for obsessive compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}